Lars J.S. Knutsen,Martin E. Cooper,Andrew W. Brown
申请号：
US15842823
公开号：
US20190185437A1
申请日:
2017.12.14
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention relates to compounds suitable for treating, ameliorating and/or preventing neuromuscular disorders, including the reversal of drug-induced neuromuscular blockade. The compounds as defined herein preferably inhibit the ClC-1 ion channel.
